Reexamination reopens prosecution on a patent that has already granted.
An examiner looks at the claims again, against prior art the Office may not have considered properly the first time.
Two types survive. Ex parte reexamination, which anyone can request, and supplemental examination, which only the patent owner can use.
Inter partes reexamination is gone, replaced by inter partes review in 2012 — which is why older material describing three types is out of date.
The two surviving types
| Ex parte reexamination | Supplemental examination | |
|---|---|---|
| Who can request | Anyone, including anonymously | Patent owner only |
| Grounds | §102/§103 on patents and printed publications | Any information |
| Purpose | Challenge or strengthen | Address inequitable conduct exposure |
| Requester participation | Minimal | N/A |
| Estoppel on the requester | None | N/A |
| Can amend claims | Patent owner can, narrowing only | Yes, if reexamination is ordered |
Ex parte reexamination is the challenge route. Supplemental examination is a patent owner's cleanup tool. See ex parte reexamination.
What happened to inter partes reexamination
| Inter partes reexamination | Replaced by | |
|---|---|---|
| Existed | Until September 2012 | Inter partes review |
| Forum | Examiner | PTAB |
| Requester participation | Limited but real | Full party |
| Timetable | None | Statutory |
Older material describing three reexamination types is out of date. Inter partes reexamination was phased out by the America Invents Act, and requests could no longer be filed after September 2012.
Inter partes review replaced it with a better-designed procedure — a real adversarial trial before administrative patent judges, on a fixed timetable. See inter partes review.
The substantial new question standard
The threshold for ordering reexamination at all.
| Requirement | Detail |
|---|---|
| A question about patentability | Raised by patents or printed publications |
| New | Not already considered in the same way |
| Substantial | A reasonable examiner would consider it important |
| Previously cited art | Can still qualify if presented in a new light |
Previously considered art is not automatically excluded. A reference the examiner cited but applied differently can support a substantial new question if the request shows it teaches something not previously appreciated.
The standard is lower than the PTAB's institution threshold, which requires a reasonable likelihood of prevailing. Reexamination is ordered more readily than inter partes review is instituted.
Reexamination versus PTAB trials
| Ex parte reexamination | Inter partes review | |
|---|---|---|
| Forum | Examiner | PTAB, three judges |
| Requester participation | Almost none | Full party |
| Cost | Much lower | Significant |
| Timetable | Ordinary examination pace | Statutory, ~18 months |
| Estoppel | None | Yes on a final written decision |
| Anonymity | Available | No |
| Deadline after being sued | None | 1 year from service |
| Claim amendment by owner | Readily available | Motion to amend, rarely granted |
| Standard | Preponderance | Preponderance |
The two big trade-offs are participation and estoppel. IPR gives you a seat at the table and takes your documentary invalidity case; reexamination gives you neither.
Amendment availability cuts against the challenger in reexamination. The patent owner can narrow claims through ordinary prosecution, which may produce a valid patent that still reads on the accused product.
Why anonymity matters
| Situation | Benefit |
|---|---|
| Challenging without revealing interest | Available in ex parte reexamination |
| Avoiding a declaratory judgment counterclaim | Possible |
| Not signalling a product launch | Possible |
| Outside the one-year IPR bar | Reexamination has no equivalent bar |
A party barred from IPR by the one-year rule can still file a reexamination request, which is one of the main practical reasons the route survives.
Anonymity is genuine but not absolute. A request must be filed by someone, and the surrounding circumstances frequently make the interested party obvious.
The patent owner's use
Requesting reexamination of your own patent sounds odd and is a real strategy.
| Goal | How it works |
|---|---|
| Strengthen before asserting | Surviving the best prior art makes later challenges harder |
| Address art found late | Get it considered rather than leaving it hanging |
| Fix a known weakness | Amend narrowly and deliberately |
| Supplemental examination | Remove inequitable conduct exposure |
The risk is real. Claims can be narrowed or cancelled, and the process is not controllable once ordered.
But a patent that has survived reexamination over strong art is materially harder to attack. An accused party has to find something the Office has now considered twice.
Supplemental examination specifically
| Feature | Detail |
|---|---|
| Who | Patent owner only |
| Purpose | Have the Office consider information relevant to patentability |
| Effect if the patent survives | That information generally cannot support inequitable conduct |
| Grounds | Any information, not just patents and publications |
| Outcome | May lead to ex parte reexamination being ordered |
It exists to address the inequitable conduct problem. A patent holder who discovers material art that should have been disclosed during prosecution faces potential unenforceability of the entire patent — a far worse outcome than narrower claims.
Supplemental examination converts that risk into a narrower question. Submit the information, let the Office consider it, and the unenforceability argument is largely removed if the patent survives.
It is not a complete shield. It does not protect against conduct already pleaded in litigation, and it must be used before the issue arises.
What can and cannot be raised
| Ground | Ex parte reexamination |
|---|---|
| §102 anticipation, on documents | Yes |
| §103 obviousness, on documents | Yes |
| Prior public use | No |
| On-sale activity | No |
| §101 eligibility | No |
| §112 enablement or definiteness | No |
| Inequitable conduct | No |
The documentary limitation matches inter partes review. Both are confined to patents and printed publications, which is why the choice between them turns on process rather than grounds.
Grounds outside that set stay in district court, where any invalidity theory is available at the clear and convincing standard. See patent invalidation.
Worked example: choosing the route
A company sued 14 months ago, holding two printed publications.
| Option | Available? | Why |
|---|---|---|
| Inter partes review | No | One-year bar passed |
| Post-grant review | No | Well outside the nine-month window |
| Ex parte reexamination | Yes | No deadline |
| District court invalidity defence | Yes | Clear and convincing standard |
What reexamination offered
| Factor | Assessment |
|---|---|
| Cost | A fraction of the litigation validity fight |
| Standard | Preponderance, better than court |
| Estoppel | None — defence preserved in court |
| Participation | Almost none — a genuine drawback |
| Amendment risk | Patent owner may narrow to something still infringed |
| Stay prospects | Weaker than with an instituted IPR |
The one-year bar drove the decision. Having missed the IPR window, reexamination was the only route to the preponderance standard.
No estoppel meant the district court defence stayed intact, so the request cost nothing strategically even if it failed.
The amendment risk was the real concern. If the owner narrowed the claims to distinguish the references while still covering the product, the reexamination would have strengthened the patent rather than defeating it.
Concurrent proceedings
| Situation | Effect |
|---|---|
| Reexamination alongside district court litigation | Court may stay, less readily than for IPR |
| Reexamination alongside an IPR | Board may address the overlap |
| Two reexaminations on one patent | May be merged |
| Reissue and reexamination together | Frequently merged |
Stays are harder to obtain than with an instituted IPR, because reexamination has no statutory end date and a court cannot predict when it will conclude.
Merger is common where proceedings overlap, and it can extend timelines further.
Outcomes
| Outcome | Meaning |
|---|---|
| Certificate confirming claims | Claims survive unchanged — patent is stronger |
| Certificate with amended claims | Narrower claims, intervening rights may apply |
| Certificate cancelling claims | Those claims are gone |
| Mixed | Common — some confirmed, some amended, some cancelled |
Intervening rights matter after amendment. A party who began practising the invention before the amended claims issued may have rights that limit enforcement against them.
Confirmation is a real risk for a challenger. A patent that emerges confirmed is harder to attack afterwards than it was before the request.
Fees and cost profile
| Item | Note |
|---|---|
| USPTO request fee | Substantial, non-refundable |
| Preparing the request | The main cost |
| Requester's ongoing costs | Essentially none after filing |
| Patent owner's costs | Ongoing, through prosecution |
The cost asymmetry runs the other way here. A challenger's spending stops at filing; the patent owner then funds a full prosecution cycle.
That is a real strategic feature, distinct from the merits, and it is one reason reexamination is used against owners with limited resources.
Timing
| Stage | Nature |
|---|---|
| Request filed | With fee and a statement of the SNQ |
| Order or denial | Within about three months |
| Patent owner statement | Optional |
| Requester reply | Only if the owner filed a statement |
| Examination | Ordinary office action and response cycles |
| Certificate issues | When prosecution concludes |
There is no statutory deadline for completion, which is the main structural difference from a PTAB trial. Reexamination follows ordinary examination pace and can run considerably longer than eighteen months.
That unpredictability weakens stay applications. A court asked to stay litigation pending a proceeding with no end date is less likely to grant it.
Reissue: the adjacent procedure
| Reexamination | Reissue | |
|---|---|---|
| Who files | Anyone, or the owner | Owner only |
| Purpose | Test validity over prior art | Correct a defective patent |
| Can broaden claims | No | Yes, within 2 years of grant |
| Can narrow claims | Yes | Yes |
| Replaces the original | No — certificate issues | Yes |
Reissue is the only route to broader claims after grant, and the two-year window for broadening is strict.
The two are frequently confused because both reopen an issued patent, but their purposes are opposite: one tests validity, the other fixes errors.
Reexamination: the checklist
- Check whether you are inside the IPR one-year bar first. If you are, compare both routes properly.
- Confirm your grounds are documentary. Only patents and printed publications qualify.
- Frame a substantial new question, and remember previously cited art can qualify if presented in a new light.
- Weigh estoppel heavily. Reexamination creates none for the requester; IPR does.
- Accept that you will not participate after the initial exchange.
- Model the amendment risk. A narrowed but valid patent may still cover your product.
- Consider anonymity if revealing your interest would trigger a counterclaim or signal a launch.
- As a patent owner, consider requesting it yourself before asserting, to strengthen the patent.
- Use supplemental examination where undisclosed material art creates inequitable conduct exposure.
- Expect no fixed timetable, and factor that into any stay application.